Shamin Rahimi
University of California System(US)University of California San Diego(US)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Nitric Oxide and Endothelin Effects, Ion channel regulation and function, Cardiovascular Function and Risk Factors, MicroRNA in disease regulation
Most-Cited Works
- → MicroRNA-mediated downregulation of K+ channels in pulmonary arterial hypertension(2019)36 cited
- → Halofuginone, a promising drug for treatment of pulmonary hypertension(2021)34 cited
- → Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused/ventilated mouse lung(2020)28 cited
- → Notch enhances Ca2+ entry by activating calcium-sensing receptors and inhibiting voltage-gated K+ channels(2020)28 cited
- → Established pulmonary hypertension in rats was reversed by a combination of a HIF‐2α antagonist and a p53 agonist(2021)26 cited
- → Endothelial platelet‐derived growth factor‐mediated activation of smooth muscle platelet‐derived growth factor receptors in pulmonary arterial hypertension(2020)20 cited
- → Hypoxic Pulmonary Vasoconstriction in Isolated Mouse Lungs(2020)
- → Halofuginone Induces Pulmonary Vasodilation by Activating KCNA5 Channels and Inhibiting Extracellular Ca 2+ -Induced Ca 2+ Influx(2020)
- → Calcium Homeostasis Modulator (CALHM1/2) and Pulmonary Arterial Hypertension(2020)
- → Using Pulmonary Angiogram to Estimate Vascular Remodeling in Mice(2020)